Knowledge Distillery

Ocrelizumab maintains B-cell depletion via six-monthly dosing. Whilst this controls relapsing multiple sclerosis, it also inhibits seroconversion…

This study aimed to investigate the factors affecting the unwillingness of physicians involved in epilepsy care to continue telemedicine during the…

The objective of this case-control study was to assess risk factors for persistent neuropathic pain in subjects recovered from COVID-19 and to study…

Apolipoprotein E ε4 allele (APOE4) has been shown to associate with increased susceptibility to SARS-CoV-2 infection and COVID-19 mortality in some…

The objective of this article was to study the longitudinal seizure outcomes of people with epilepsy (PWE) following the acute and chronic phases of…

The objective of this study was to describe cerebrovascular, neuropathic and autonomic features of post-acute sequelae of COVID-19 (PASC). This…

In Switzerland, the COVID-19 incidence during the first pandemic wave was high. In this article the authors aimed to assess the association of the…

Creutzfeldt-Jakob disease (CJD) is lethal and transmissible. In this article the authors assessed the impact of the COVID-19 pandemic on UK CJD…

Cerebral Venous Sinus Thrombosis (CVST) as a part of the thrombosis and thrombocytopenia syndrome is a rare adverse drug reaction of SARS-CoV-2…

Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease…

Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence…

The objective of this study was to understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis…